Trichloroacetic acid (50%) in the treatment of venous leg ulcers.


Journal

Journal de medecine vasculaire
ISSN: 2542-4513
Titre abrégé: J Med Vasc
Pays: France
ID NLM: 101709200

Informations de publication

Date de publication:
May 2021
Historique:
received: 27 02 2021
accepted: 22 03 2021
entrez: 15 5 2021
pubmed: 16 5 2021
medline: 29 10 2021
Statut: ppublish

Résumé

Leg ulcers are a chronic and disabling condition that is difficult, time-consuming and costly to treat. We report a study evaluating the efficacy of trichloroacetic acid in the treatment of venous leg ulcers. We treated 19 patients with leg ulcers with 50% trichloroacetic acid with one application per week for 6 weeks. The primary evaluation criteria was healing, assessed by measuring the surface area of the ulcer before and after treatment. We included 13 men and 6 women, with venous leg ulcers, with an average age of 57 years. The mean ulcer duration was 2.9 years. Complete healing was achieved in 2 patients, good healing in 9 patients, moderate healing in 6 patients, and poor healing in 2 patients. Our study supports the data in the literature from two published series, and suggests that 50% trichloroacetic acid would be a good therapeutic alternative with satisfactory wound healing, low cost, and absence of adverse effects.

Identifiants

pubmed: 33990288
pii: S2542-4513(21)00052-3
doi: 10.1016/j.jdmv.2021.03.006
pii:
doi:

Substances chimiques

Trichloroacetic Acid 5V2JDO056X

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

139-143

Informations de copyright

Copyright © 2021 Elsevier Masson SAS. All rights reserved.

Auteurs

L Zenjari (L)

Department of dermatology and venerology, CHU Ibn Rochd, Casablanca, Morocco. Electronic address: leila-zenjari@hotmail.fr.

F Hali (F)

Department of dermatology and venerology, CHU Ibn Rochd, Casablanca, Morocco.

S Chiheb (S)

Department of dermatology and venerology, CHU Ibn Rochd, Casablanca, Morocco.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH